Background Long noncoding RNAs (lncRNAs) play widespread roles in gene regulation and cellular processes. However, the functional roles of lncRNAs in colorectal cancer (CRC) are not yet well elucidated. The aim of the present study was to measure the levels of lncRNA 91H expression in CRC and evaluate its clinical significance and biological roles in the development and progression of CRC. Methods 91H expression and copy number variation (CNV) were measured in 72 CRC tumor tissues and adjacent normal tissues by real-time PCR. The biological roles of 91H were evaluated by MTT, scratch wound assay, migration and invasion assays, and flow cytometry. Results 91H was significantly overexpressed in cancerous tissue and CRC cell lines compared with adjacent normal tissue and a normal human intestinal epithelial cell line. Moreover, 91H overexpression was closely associated with distant metastasis and poor prognosis in patients with CRC, except for CNV of 91H. Multivariate analysis indicated that 91H expression was an independent prognostic indicator, as well as distant metastasis. Our in vitro data indicated that knockdown of 91H inhibited the proliferation, migration, and invasiveness of CRC cells. Conclusions 91H played an important role in the molecular etiology of CRC and might be regarded as a novel prognosis indicator in patients with CRC.
References
[1]
International Agency for Research on Cancer (IARC) (2012) Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012.
[2]
Li HZ, Mao WM, Wang XH, Yu CD, Du LB (2013) [Incidence and mortality of cancer in Zhejiang province in 2009]. Zhonghua Yu Fang Yi Xue Za Zhi 47: 592–596.
[3]
Kim J, Huynh R, Abraham I, Kim E, Kumar RR (2006) Number of lymph nodes examined and its impact on colorectal cancer staging. Am Surg 72: 902–905.
[4]
Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259–269. doi: 10.1038/nrc1840
[5]
Hammond SM (2006) MicroRNAs as oncogenes. Curr Opin Genet Dev 16: 4–9.
[6]
Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, et al. (2013) The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 45: 1392–1398. doi: 10.1038/ng.2771
[7]
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071–1076. doi: 10.1038/nature08975
[8]
Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, et al. (2011) lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477: 295–300. doi: 10.1038/nature10398
[9]
Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, et al. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689–693. doi: 10.1126/science.1192002
[10]
Nagano T, Fraser P (2011) No-nonsense functions for long noncoding RNAs. Cell 145: 178–181. doi: 10.1016/j.cell.2011.03.014
[11]
Wilusz JE, Sunwoo H, Spector DL (2009) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23: 1494–1504. doi: 10.1101/gad.1800909
[12]
Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, et al. (2014) Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 110: 164–171.
[13]
Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, et al. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311–1323. doi: 10.1016/j.cell.2007.05.022
[14]
Berteaux N, Aptel N, Cathala G, Genton C, Coll J, et al. (2008) A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression. Mol Cell Biol 28: 6731–6745. doi: 10.1128/mcb.02103-07
[15]
Buhard O, Cattaneo F, Wong YF, Yim SF, Friedman E, et al. (2006) Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J Clin Oncol 24: 241–251. doi: 10.1200/jco.2005.02.7227
[16]
Tran VG, Court F, Duputie A, Antoine E, Aptel N, et al. (2012) H19 antisense RNA can up-regulate Igf2 transcription by activation of a novel promoter in mouse myoblasts. PLoS ONE 7: e37923. doi: 10.1371/journal.pone.0037923
[17]
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494–498. doi: 10.1038/35078107
[18]
Svoboda M, Slyskova J, Schneiderova M, Makovicky P, Bielik L, et al.. (2014) HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis.
[19]
Greiner M, Pfeiffer D, Smith RD (2000) Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 45: 23–41. doi: 10.1016/s0167-5877(00)00115-x
[20]
Necsulea A, Soumillon M, Warnefors M, Liechti A, Daish T, et al. (2014) The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 505: 635–640. doi: 10.1038/nature12943
[21]
Orom UA, Shiekhattar R (2013) Long noncoding RNAs usher in a new era in the biology of enhancers. Cell 154: 1190–1193. doi: 10.1016/j.cell.2013.08.028
[22]
Gomez JA, Wapinski OL, Yang YW, Bureau JF, Gopinath S, et al. (2013) The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell 152: 743–754. doi: 10.1016/j.cell.2013.01.015
[23]
Gao T, He B, Pan Y, Xu Y, Li R, et al.. (2014) Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression. Mol Carcinog.
[24]
Takahashi Y, Sawada G, Sato T, Kurashige J, Mima K, et al. (2013) Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis. Oncol Rep 30: 1488–1496. doi: 10.3892/or.2013.2602
[25]
Chen FJ, Sun M, Li SQ, Wu QQ, Ji L, et al. (2013) Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog 52: 908–915. doi: 10.1002/mc.21944
[26]
Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, et al. (2011) Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71: 6320–6326. doi: 10.1158/0008-5472.can-11-1021
[27]
Bochner BH, Kattan MW, Vora KC (2006) Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 24: 3967–3972. doi: 10.1200/jco.2005.05.3884
[28]
Karakiewicz PI, Briganti A, Chun FK, Trinh QD, Perrotte P, et al. (2007) Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 25: 1316–1322. doi: 10.1200/jco.2006.06.1218
[29]
Wierda WG, O’Brien S, Wang X, Faderl S, Ferrajoli A, et al. (2007) Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 109: 4679–4685. doi: 10.1182/blood-2005-12-051458
[30]
Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26: 1364–1370. doi: 10.1200/jco.2007.12.9791
[31]
Yoshihara K, Tajima A, Adachi S, Quan J, Sekine M, et al. (2011) Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes Chromosomes Cancer 50: 167–177. doi: 10.1002/gcc.20841
[32]
Yu KD, Shao ZM (2009) Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms. Nat Rev Cancer 9: 842. doi: 10.1038/nrc2683-c1
[33]
Bruce S, Hannula-Jouppi K, Puoskari M, Fransson I, Simola KO, et al. (2010) Submicroscopic genomic alterations in Silver-Russell syndrome and Silver-Russell-like patients. J Med Genet 47: 816–822. doi: 10.1136/jmg.2009.069427
[34]
Demars J, Rossignol S, Netchine I, Lee KS, Shmela M, et al. (2011) New insights into the pathogenesis of Beckwith-Wiedemann and Silver-Russell syndromes: contribution of small copy number variations to 11p15 imprinting defects. Hum Mutat 32: 1171–1182. doi: 10.1002/humu.21558
[35]
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17: 1471–1474. doi: 10.1245/s10434-010-0985-4
